// App-Quantinova.ai

Tu1640 : THE INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B (PTP1B) RECOVERS IMPAIRED VAGAL AFFERENT INDUCED DURING DIET-INDUCED OBESITY THROUGH REDUCTION IN NITRIC OXIDE AND TWO-PORE DOMAIN K+ CONDUCTANCE

Researchers

Presenter

  • Michael Beyak

Principal Investigators

  • N/A

Medical Centers

  • Gastroenterology / Medicine, Queen's University, Kingston, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • Nitric oxide

  • Nucleoside diphosphate kinase A

  • Protein tyrosine phosphatase 1B

  • Leptin

Drug/Treatment

  • Nitric oxide

  • L-Tyrosine

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved